首页> 美国卫生研究院文献>Computational and Structural Biotechnology Journal >CRISPR-Cas systems: Overview innovations and applications in human disease research and gene therapy
【2h】

CRISPR-Cas systems: Overview innovations and applications in human disease research and gene therapy

机译:CRISPR-CAS系统:人类疾病研究和基因治疗的概述创新和应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Genome editing is the modification of genomic DNA at a specific target site in a wide variety of cell types and organisms, including insertion, deletion and replacement of DNA, resulting in inactivation of target genes, acquisition of novel genetic traits and correction of pathogenic gene mutations. Due to the advantages of simple design, low cost, high efficiency, good repeatability and short-cycle, CRISPR-Cas systems have become the most widely used genome editing technology in molecular biology laboratories all around the world. In this review, an overview of the CRISPR-Cas systems will be introduced, including the innovations, the applications in human disease research and gene therapy, as well as the challenges and opportunities that will be faced in the practical application of CRISPR-Cas systems.
机译:基因组编辑是在各种细胞类型和生物中的特定靶位点的修饰,包括插入,缺失和替换DNA,导致靶基因的灭活,采取新的遗传性状和致病性基因突变的校正。由于设计简单,成本低,效率高,重复性良好,短周期,CRISPR-CAS系统已成为全球分子生物学实验室中使用的最广泛使用的基因组编辑技术。在本次审查中,将引入CRISPR-CAS系统的概述,包括创新,人类疾病研究和基因治疗中的应用,以及将在CRISPR-CAS系统的实际应用中面临的挑战和机遇。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号